Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy

Diabetic Medicine

Volumn 32, Issue 11, 2015, Pages 1479-1483

  Herder, C ^a,b   Bongaerts, B W C ^a   Ouwens, D M ^a,b,c   Rathmann, W ^a   Heier, M ^d   Carstensen Kirberg, M ^a,b   Koenig, W ^e   Thorand, B ^d,f   Roden, M ^a,b   Meisinger, C ^d   Ziegler, D ^a,b   Peters, A ^g   Heinrich, J ^g   Holle, R ^g   Leidl, R ^g   Strauch, K ^g  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b German Center of Diabetes Research DZD e V   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^g Heinrich Heine University Düsseldorf ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; OMENTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; TNF PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETIC NEUROPATHY; DIABETIC SENSORIMOTOR POLYNEUROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OMENTIN BLOOD LEVEL; PHYSICAL ACTIVITY; POLYNEUROPATHY; PRESSURE SENSATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; VIBRATION SENSE; AGING; BLOOD; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHIES; DOWN REGULATION; GERMANY; HEALTH SURVEY; POLYNEUROPATHIES; VERY ELDERLY;

ADIPONECTIN; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; GPI-LINKED PROTEINS; HEALTH SURVEYS; HUMANS; LECTINS; MALE; POLYNEUROPATHIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945496130     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12761     Document Type: Article

References (19)

1. Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 2013; 36: 2456-2465.
2. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290: E1253-E1261.
3. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011; 408: 339-343.
4. Greulich S, Chen WJ, Maxhera B, Rijzewijk LJ, van der Meer RW, Jonker JT et al. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One 2013; 8: e59697.
5. Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol 2014; 63: 2722-2733.
6. Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G et al. Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors. KORA S4/F4 cohort study. Diabet Med 2009; 26: 1212-1219.
7. World Health Organisation. Report of a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: World Health Organization, 1999.
8. Bongaerts BW, Rathmann W, Kowall B, Herder C, Stöckl D, Meisinger C et al. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 2012; 35: 1891-1893.
9. Herder C, Ouwens DM, Carstensen M, Kowall B, Huth C, Meisinger C et al. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol 2015; 172:423-432.
10. Herder C, Bongaerts BW, Rathmann W, Heier M, Kowall B, Koenig W et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care 2013; 36: 3663-3670.
11. Herder C, Carstensen M, Ouwens DM. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 2013; 15(Suppl 3): 39-50.
12. Akiyama Y, Oshima K, Kuhara T, Shin K, Abe F, Iwatsuki K et al. A lactoferrin-receptor, intelectin 1, affects uptake, sub-cellular localization and release of immunochemically detectable lactoferrin by intestinal epithelial Caco-2 cells. J Biochem 2013; 154: 437-448.
13. Moreno-Navarrete JM, Ortega FJ, Bassols J, Ricart W, Fernandez-Real JM. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 4036-4044.
14. Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Po-Bosui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 2007; 56: 2997-3005.
15. Putz Z, Martos T, Németh N, Körei AE, Vági OE, Kempler MS et al. Is there an association between diabetic neuropathy and low vitamin D levels? Curr Diab Rep 2014; 14: 537.
16. Ziegler D, Buchholz S, Sohr C, Nourooz-Zadeh J, Roden M. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients. Acta Diabetol 2015; 52: 65-72.
17. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 2009; 94: 2157-2163.
18. Scalabrino G. Vitamin-regulated cytokines and growth factors in the CNS and elsewhere. J Neurochem 2009; 111: 1309-1326.
19. Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012; 2012: 878760.